Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Operating activities
Net income (loss)	$ 17,097	$ (1,298)	$ (22,783)
Less: Income from discontinued operations	(19,992)	(4,916)	(14,710)
Loss from continuing operations	(2,895)	(6,214)	(37,493)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Restructuring, severance and other charges	1,392	1,495	15,247
Payments for restructuring, severance and other charges	1,741	6,673	5,896
Legal settlements	0	1,664	0
Payments for legal settlements	(110)	0	0
Asset impairments and related charges	327	120	9,681
Depreciation	2,074	2,137	3,963
Amortization	6,726	4,089	5,807
Share-based compensation	2,119	1,638	2,397
Deferred income taxes	(178)	(244)	(10)
Change in cash surrender value of company owned life insurance policies	(600)	(107)	(371)
Excess tax benefit from equity awards	37	0	0
Changes in operating assets and liabilities:
Accounts receivable	(7,846)	(741)	(3,396)
Inventories	380	426	(645)
Prepaid expense	(498)	(801)	(207)
Accounts payable	1,073	1,595	(1,700)
Deferred revenue	2,784	(5,046)	7,775
Accrued liabilities	1,624	(3,170)	(2,600)
Income taxes receivable	(2,702)	(2,960)	(5,958)
Other changes, net	(508)	(258)	727
Net cash provided by (used in) operating activities from continuing operations	1,384	(13,050)	(12,679)
Net cash (used in) provided by operating activities from discontinued operations	1,311	(2,345)	9,019
Net cash provided by (used in) operating activities	73	(10,705)	(21,698)
Proceeds from sale of business units	35,846	0	55,840
Cash paid for acquisitions, net	(1,812)	0	0
Proceeds from sale of marketable securities	0	4,347	9,184
Capital expenditures	(4,023)	(2,532)	(2,231)
Capitalized software development costs	(12,200)	(3,906)	(2,585)
Additional (investments in) proceeds from corporate-owned life insurance policies	(87)	(108)	235
Net cash provided by (used in) investing activities from continuing operations	17,724	(2,199)	60,443
Net cash used in investing activities from discontinued operations	(155)	(854)	(104)
Net cash provided by (used in) investing activities	17,569	(3,053)	60,339
Financing activities
Principal payments under long-term obligations	(177)	(289)	(1,001)
Exercise of employee stock options	169	67	210
Repurchase of common shares to satisfy employee tax withholding and option price	(912)	(278)	(1,449)
Excess tax benefit from equity awards	37	0	0
Repurchase of common shares	0	0	(13,173)
Net cash used in financing activities from continuing operations	(883)	(500)	(15,413)
Net cash used in financing activities from discontinued operations	(80)	(377)	0
Net cash used in financing activities	(963)	(877)	(15,413)
Effect of exchange rate changes on cash	(44)	(21)	5
Cash flows provided by (used in) continuing operations	18,181	(15,770)	32,356
Cash flows (used in) provided by discontinued operations	(1,546)	1,114	(9,123)
Net increase (decrease) in cash and cash equivalents	16,635	(14,656)	23,233
Cash and cash equivalents at beginning of period	82,931	97,587	74,354
Cash and cash equivalents at end of period	99,566	82,931	97,587
Less cash presented in current assets of discontinued operations on balance sheet	0	487	2,076
Cash and cash equivalents at end of period - continuing operations	$ 99,566	$ 82,444	$ 95,511